According to the molecular and histological features BC could be divided into the three groups: BCs expressing hormone receptor (ER—estrogen receptor), or (PR—progesterone receptor), BCs expressing HER+ (human epidermal receptor 2) and TNBC (triple-negative breast cancers). Here, ESR1 is linked to triple-negative breast carcinoma.